A multidisciplinary team represents the biopharmaceutical company in the largest life sciences debt financing of 2021. BridgeBio Pharma (Nasdaq: BBIO) (BridgeBio or the Company), a commercial-stage biopharmaceutical company focused on…
The post Latham & Watkins Advises BridgeBio Pharma in US$750 Million Non-Dilutive Debt Financing appeared first on Legal Desire.